|
Volumn 40, Issue 2, 2008, Pages 126-136
|
Role of regulatory T cells for the treatment of type 1 diabetes mellitus
|
Author keywords
Adoptive transfer; Diabetes; Foxp3; NOD; Regulatory T cell; Tolerance
|
Indexed keywords
BETA CELL ANTIGEN;
CD3 ANTIBODY;
CELL ANTIGEN;
TRANSCRIPTION FACTOR FOXP3;
UNCLASSIFIED DRUG;
ADOPTIVE TRANSFER;
ANTIGEN PRESENTING CELL;
APOPTOSIS;
AUTOIMMUNITY;
CD4+ CD25+ T LYMPHOCYTE;
CELL EXPANSION;
CLONAL ANERGY;
CYTOKINE PRODUCTION;
EPSTEIN BARR VIRUS;
FLU LIKE SYNDROME;
HUMAN;
IMMUNOLOGICAL TOLERANCE;
IMMUNOREGULATION;
IMMUNOSUPPRESSIVE TREATMENT;
IMMUNOTHERAPY;
INFECTION SENSITIVITY;
INSULIN DEPENDENT DIABETES MELLITUS;
NATURAL KILLER T CELL;
NONHUMAN;
PATHOPHYSIOLOGY;
PRIORITY JOURNAL;
REGULATORY T LYMPHOCYTE;
REVIEW;
SIDE EFFECT;
TUMOR GROWTH;
ADOPTIVE TRANSFER;
ANIMALS;
ANTIGENS, CD4;
ANTIGENS, CD45;
CD4-POSITIVE T-LYMPHOCYTES;
DIABETES MELLITUS, TYPE 1;
FORKHEAD TRANSCRIPTION FACTORS;
HUMANS;
IMMUNE TOLERANCE;
T-LYMPHOCYTE SUBSETS;
T-LYMPHOCYTES, REGULATORY;
ANIMALIA;
|
EID: 40549120324
PISSN: 00185043
EISSN: None
Source Type: Journal
DOI: 10.1055/s-2008-1042427 Document Type: Review |
Times cited : (31)
|
References (116)
|